Bonum therapeutics融资
WebWhat is Bonum Health? Bonum Health is a digital health technology company. Our team combines compassion with technology to help people everywhere take control of their health. Our focus is on making healthcare accessible, affordable, and convenient for … WebNov 15, 2024 · Company Type For Profit. Contact Email [email protected]. Phone Number 206.888.8485. Bonum Therapeutics is creating a technology platform that can be used to treat a wide range of diseases, including cancer which is the company’s primary …
Bonum therapeutics融资
Did you know?
WebNov 15, 2024 · Seattle biotech startup Bonum Therapeutics raised $93 million less than two months after its parent company Good Therapeutics was bought for $250 million by Roche, ... WebNov 15, 2024 · Bonum Therapeutics has raised a total of $93M in funding over 1 round. This was a Series A round raised on Nov 15, 2024. Bonum Therapeutics is funded by 6 investors. Roche Venture Fund and Digitalis Ventures are the most recent investors.
WebNov 16, 2024 · Bonum Therapeutics Inc., a spinout of Good Therapeutics Inc., which Roche Holding AG acquired in August, has announced a US$93 million series A financing. Bonum is developing new therapies based on the proprietary platform of allosterically …
WebBonum Therapeutics's headquarters are located at 1616 Eastlake Avenue East Ste 400, Seattle, Washington, 98102, United States What is Bonum Therapeutics's phone number? Bonum Therapeutics's phone number is (206) 888-8485 What is Bonum … WebNov 17, 2024 · Seattle-based biotech Bonum Therapeutics has raised a $93 million Series A round. Bonum said the funding, announced Tuesday, will help the company advance its technology and find collaborators.
WebNov 15, 2024 · Permission granted by Bonum Therapeutics. Two months ago, biotechnology startup Good Therapeutics struck it big. A cancer immunotherapy the company was working on drew such interest from Roche that the Swiss pharmaceutical giant paid $250 million, far more than the $30 million the startup had raised privately, to …
WebNov 16, 2024 · 一家名为Bonum Therapeutics的初创公司宣布完成9300万美元的A轮融资。该公司开发的创新抗癌药物能在接触到肿瘤靶点后主动“变形”，精准抗癌的同时还能避免药物的副作用。 Bonum专注于开发基于其专有别构调节平台的条件性活化药物。 オステリア87 大阪WebSep 7, 2024 · With this acquisition, Roche will gain rights to Good Therapeutics’ innovative, conditionally active, PD-1-regulated IL-2 program and an exclusive right to the platform technology for the ... オステリア36高崎WebRoche Venture Fund. 医疗. 成立日期：2002. 成立地点：瑞士巴塞尔. 管理规模：-. 99+人正在监控. 项目： Bonum Therapeutics 轮次： A轮 行业： 医疗技术,医疗,生物医药. 项目： NMD Pharma 轮次： 战略融资 行业： 医疗技术,医疗. 项目： Freenome 轮次： D轮 行业： 医疗技术,医疗 ... オステリア アッサイ osteria assaiWebNov 15, 2024 · Bonum Therapeutics, a biopharmaceutical startup that uses allosteric control to develop conditionally active and less toxic medications, has announced a $93-million Series A funding round. paragon fine bone china tea setWebSep 8, 2024 · On concluding the deal, the Good Therapeutics team intends to leverage its technology to design conditionally active therapies for other immuno-oncology targets and further in a new firm, Bonum Therapeutics. Roche Pharma Partnering global head James Sabry said: “We are excited to bring Good’s innovative PD-1-regulated IL-2 programme … paragon fitness pricesWebFrom Good to Great: Bonum Therapeutics Raises $93M Series A with Allosterically Regulated Medicines The Seattle-based start-up seeks to develop safe,… Liked by Rhonda Knudsen オステリア アル コラッロ osteria al coralloWebBonum Therapeutics is a biopharmaceutical company using allosteric regulation to create conditionally active and less toxic medicines. Use the CB Insights Platform to explore Bonum Therapeutics's full profile. オステリア イタリアーナ コバ osteria italiana cova